Cargando…
DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features
The drug development process consumes 9–12 years and approximately one billion US dollars in costs. Due to the high finances and time costs required by the traditional drug discovery paradigm, repurposing old drugs to treat cancer and rare diseases is becoming popular. Computational approaches are m...
Autores principales: | Wang, Yinyin, Aldahdooh, Jehad, Hu, Yingying, Yang, Hongbin, Vähä-Koskela, Markus, Tang, Jing, Tanoli, Ziaurrehman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729186/ https://www.ncbi.nlm.nih.gov/pubmed/36477604 http://dx.doi.org/10.1038/s41598-022-24980-2 |
Ejemplares similares
-
Using BERT to identify drug-target interactions from whole PubMed
por: Aldahdooh, Jehad, et al.
Publicado: (2022) -
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
por: Tanoli, Ziaurrehman, et al.
Publicado: (2020) -
DrugComb: an integrative cancer drug combination data portal
por: Zagidullin, Bulat, et al.
Publicado: (2019) -
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
por: Zheng, Shuyu, et al.
Publicado: (2022) -
Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments
por: Tanoli, Ziaurrehman, et al.
Publicado: (2021)